S100A9 and Miyoshi myopathy: De Veirman et al. [84] analysed the potential role of extracellular S100A9 in MM using the 5T33MM immunocompetent mouse in which MM progression is characterised by an accumulation of MDSC in the BM and an increase in angiogenesis.